Award recordCONTRACT

JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.

PIID 36C26020F0674· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $127,189 net obligations· UEI EQ4VSLH8RC33· FL

Description

RADIOPHARMACEUTICALS FOR PORTLAND VAMC

First action · last action
2020-07-01 · 2022-04-21
Transactions
3
First transaction's obligation
$132,500
Base + all options value (sum of deltas)
$127,189
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA26017D0044
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$132,500$0Base award · 2020-07-01 · this action $132,500 · running total $132,500Modification P00001 · 2021-04-28 · this action $0 · running total $132,500Modification P00002 · 2022-04-21 · this action -$5,311 · running total $127,189
  • Base2020-07-01+$132,500= $132,500
  • Mod P000012021-04-28+$0= $132,500
  • Mod P000022022-04-21-$5,311= $127,189
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-07-01+$132,500$132,500RADIOPHARMACEUTICALS FOR PORTLAND VAMC
Mod P00001· OTHER ADMINISTRATIVE ACTION2021-04-28+$0$132,500RADIOPHARMACEUTICALS FOR PORTLAND VAMC
Mod P00002· FUNDING ONLY ACTION2022-04-21−$5,311$127,189RADIOPHARMACEUTICALS FOR PORTLAND VAMC

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EQ4VSLH8RC33)

AwardOffice · PSC / listingNet obligationsFY
36C24826N0411248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$231,773FY2026
36C24126N0274241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$771,411FY2026
36C25226N0210252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$164,999FY2026
36C26126N0065261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$153,991FY2026
36C24825N0208248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$224,563FY2025
36C24125N0495241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$656,883FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26020F0674_3600_VA26017D0044_3600 · retrieved 2026-09-26.